1. Medtech Insight
  2. >>Business

The Top 10 Medtech Themes For 2022 – And M&A Trends

Medtechs are ready to get back to their old agenda in defining the new era of health care

 
• By Ashley Yeo

The operating environment for medical technology companies becomes more complex, competitive and costly every year. There is no expectation that 2022 will buck that trend, even as the medtech sector prepares for a third year of working under conditions shaped by the COVID-19 pandemic.

Shipping containers
• Source: Alamy

The top themes and talking points that will influence medtech decision-making and operating conditions in 2022 are listed below.

Although there were some positional changes among the ranking of the leading 20 medtechs by sales in COVID-affected 2020, the overall composition was unchanged compared with 2019 (the restatement of Alcon Inc.’s sales to exclude consumer/OTC ophthalmology revenues excepted).(Also see "MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other" - Medtech Insight, 6 December, 2021.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

Beyond The Bladder: Incontinence Impacts Mental Health

 
• By Brian Bossetta

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

AI Rollout Aims To Accelerate FDA’s Product Review Process

 
• By Elizabeth Orr

The FDA plans to implement artificial intelligence in its scientific review process by 30 June, following a successful pilot. The agency hopes the tool will reduce nonproductive tasks for reviewers amid recent staff cuts. A Chief AI Officer will oversee the rollout and integration.

Access To Library Tools Being Restored At US FDA

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals and laid off librarians have not been reinstated.